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Epigenetic gene silencing by aberrant DNA methylation is one of the important mechanisms leading to the loss of 
key cellular pathways in tumorigenesis. Methyl-CpG targeted transcriptional activation (MeTA) reactivates 
hypermethylation-mediated silenced genes in a different way from DNA demethylating agents. Previous pilot 
study using microarray coupled with MeTA (MeTA-array) identified seven commonly 
hypermethylation-mediated silenced genes in pancreatic cancer cell lines. In this study, IRX4 (Iroquois homeobox 
4) was focused on because this gene has recently been identified as a candidate tumor suppressor gene in prostate 
cancer. IRX4 was greatly downregulated in all the analyzed pancreatic cancer cell lines by promoter 
hypermethylation. In addition, IRX4 promoter region was found to be frequently and specifically 
hypermethylated in primary resected pancreatic cancers (15/22: 68%); corresponding normal pancreatic tissues 
were unmethylated. Tetracycline-associated IRX4 inducible expression system was constructed and a pancreatic 
cancer cell line PK-1 was analyze for further functional investigation; induction of IRX4 suppressed cell growth of 
PK-1. DNA methylation-mediated silencing of IRX4 is suggested as a frequent event that may confer growth 
advantage on pancreatic cancer. 
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